Foresite Capital Fund I, L.P.
Related Filers (9)
- Foresite Capital Management I, LLC (10)
- Tananbaum James B. (10)
- 10x Genomics, Inc. (10)
- Foresite Capital Management II, LLC (8)
- Foresite Capital Fund II, L.P. (8)
- AMBIT BIOSCIENCES CORP (4)
- Karyopharm Therapeutics Inc. (2)
- Foresite Capital Fund IV, L.P. (1)
- Foresite Capital Management IV, LLC (1)
- Show More ...
Other (2)
D/A
Wednesday, 12/12/2012
Exempt (Private) Offering
D
Tuesday, 12/11/2012
Exempt (Private) Offering
Ownership (16)
SC 13G/A
Tuesday, 2/16/2021
10x Genomics, Inc.: Major Shareholders
4
Thursday, 5/14/2020
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/8/2020
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/24/2020
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/15/2020
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/26/2020
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/19/2020
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 2/14/2020
10x Genomics, Inc.: Major Shareholders
4
Monday, 9/16/2019
10x Genomics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/11/2019
10x Genomics, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Wednesday, 2/11/2015
Karyopharm Therapeutics Inc.: Major Shareholders
SC 13G/A
Friday, 2/14/2014
AMBIT BIOSCIENCES CORP: Major Shareholders
SC 13G
Friday, 11/15/2013
Karyopharm Therapeutics Inc.: Major Shareholders
3
Wednesday, 10/16/2013
AMBIT BIOSCIENCES CORP: Initial statement of beneficial ownership of securities
4
Wednesday, 10/16/2013
AMBIT BIOSCIENCES CORP: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 6/24/2013
AMBIT BIOSCIENCES CORP: Major Shareholders